Artificial intelligence (AI) use in dermatology is primed to become a powerful tool in skin cancer assessment, but it remains to be seen how diagnostic devices in dermatology will influence decision making in the clinic and affect patient outcomes, according to the authors of a perspective published online today by the Medical Journal of Australia.
In dermatology the primary focus for the use of AI has been on developing machine learning systems that facilitate classification and decision support for skin cancer management.
